Assessing the usefulness of randomised trials in obstetrics and gynaecology

Janneke van 't Hooft; Charlotte E van Dijk; Cathrine Axfors; Zarko Alfirevic; Martijn A Oudijk; Khalid S Khan; Ben W J Mol; Patrick M Bossuyt; John P A Ioannidis

doi:10.1111/1471-0528.17411

Assessing the usefulness of randomised trials in obstetrics and gynaecology

Janneke van 't Hooft^* (Corresponding Author), Charlotte E van Dijk, Cathrine Axfors, Zarko Alfirevic, Martijn A Oudijk, Khalid S Khan, Ben W J Mol, Patrick M Bossuyt, John P A Ioannidis

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

4 Citations (Scopus)

4 Downloads (Pure)

https://www.vimeo.com/785911255

Abstract

Healthcare professionals will be familiar with how little of what they read in medical journals is of direct value (useful) to their practice. Randomised controlled trials (RCTs) are traditionally placed at the top of the hierarchy of evidence validity for healthcare interventions. However, even the majority of RCTs do not seem useful in that they may not lead to any tangible improvements in clinical decision making. Increasing the usefulness of RCTs can benefit society, providing better solutions for patient problems and reducing waste in medical research budgets. In this commentary we discuss the usefulness of RCTs for healthcare interventions and propose a tool for structured assessment. We describe some examples of where RCTs have demonstrated usefulness in the field of women's health and some where they may have been less useful.

This article includes Author Insights, a video abstract available at: https://vimeo.com/785911255

Original language	English
Pages (from-to)	695-701
Number of pages	7
Journal	BJOG : an international journal of obstetrics and gynaecology
Volume	130
Issue number	7
Early online date	19 Feb 2023
DOIs	https://doi.org/10.1111/1471-0528.17411
Publication status	Published - Jun 2023

Bibliographical note

FUNDING INFORMATION
The study was funded by a grant from the Netherlands Organization for Health Research and Development (ZonMw Rubicon grant #452182306). The funder had no involvement in any phase of this study.

Access to Document

10.1111/1471-0528.17411Licence: CC BY-NC-ND

Van t Hooft_etal_BJOG_ Assessing_the_usefulness_VOR
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.© 2023 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.
Final published version, 858 KBLicence: CC BY-NC-ND

Cite this

@article{ee6b73ddd7b641209858a528db820719,

title = "Assessing the usefulness of randomised trials in obstetrics and gynaecology",

abstract = "Healthcare professionals will be familiar with how little of what they read in medical journals is of direct value (useful) to their practice. Randomised controlled trials (RCTs) are traditionally placed at the top of the hierarchy of evidence validity for healthcare interventions. However, even the majority of RCTs do not seem useful in that they may not lead to any tangible improvements in clinical decision making. Increasing the usefulness of RCTs can benefit society, providing better solutions for patient problems and reducing waste in medical research budgets. In this commentary we discuss the usefulness of RCTs for healthcare interventions and propose a tool for structured assessment. We describe some examples of where RCTs have demonstrated usefulness in the field of women's health and some where they may have been less useful.This article includes Author Insights, a video abstract available at: https://vimeo.com/785911255",

author = "{van 't Hooft}, Janneke and {van Dijk}, {Charlotte E} and Cathrine Axfors and Zarko Alfirevic and Oudijk, {Martijn A} and Khan, {Khalid S} and Mol, {Ben W J} and Bossuyt, {Patrick M} and Ioannidis, {John P A}",

note = "FUNDING INFORMATION The study was funded by a grant from the Netherlands Organization for Health Research and Development (ZonMw Rubicon grant #452182306). The funder had no involvement in any phase of this study.",

year = "2023",

month = jun,

doi = "10.1111/1471-0528.17411",

language = "English",

volume = "130",

pages = "695--701",

journal = "BJOG : an international journal of obstetrics and gynaecology",

issn = "1470-0328",

publisher = "John Wiley & Sons, Ltd (10.1111)",

number = "7",

}

TY - JOUR

T1 - Assessing the usefulness of randomised trials in obstetrics and gynaecology

AU - van 't Hooft, Janneke

AU - van Dijk, Charlotte E

AU - Axfors, Cathrine

AU - Alfirevic, Zarko

AU - Oudijk, Martijn A

AU - Khan, Khalid S

AU - Mol, Ben W J

AU - Bossuyt, Patrick M

AU - Ioannidis, John P A

N1 - FUNDING INFORMATION The study was funded by a grant from the Netherlands Organization for Health Research and Development (ZonMw Rubicon grant #452182306). The funder had no involvement in any phase of this study.

PY - 2023/6

Y1 - 2023/6

N2 - Healthcare professionals will be familiar with how little of what they read in medical journals is of direct value (useful) to their practice. Randomised controlled trials (RCTs) are traditionally placed at the top of the hierarchy of evidence validity for healthcare interventions. However, even the majority of RCTs do not seem useful in that they may not lead to any tangible improvements in clinical decision making. Increasing the usefulness of RCTs can benefit society, providing better solutions for patient problems and reducing waste in medical research budgets. In this commentary we discuss the usefulness of RCTs for healthcare interventions and propose a tool for structured assessment. We describe some examples of where RCTs have demonstrated usefulness in the field of women's health and some where they may have been less useful.This article includes Author Insights, a video abstract available at: https://vimeo.com/785911255

AB - Healthcare professionals will be familiar with how little of what they read in medical journals is of direct value (useful) to their practice. Randomised controlled trials (RCTs) are traditionally placed at the top of the hierarchy of evidence validity for healthcare interventions. However, even the majority of RCTs do not seem useful in that they may not lead to any tangible improvements in clinical decision making. Increasing the usefulness of RCTs can benefit society, providing better solutions for patient problems and reducing waste in medical research budgets. In this commentary we discuss the usefulness of RCTs for healthcare interventions and propose a tool for structured assessment. We describe some examples of where RCTs have demonstrated usefulness in the field of women's health and some where they may have been less useful.This article includes Author Insights, a video abstract available at: https://vimeo.com/785911255

UR - https://vimeo.com/785911255

U2 - 10.1111/1471-0528.17411

DO - 10.1111/1471-0528.17411

M3 - Comment/debate

C2 - 36696225

SN - 1470-0328

VL - 130

SP - 695

EP - 701

JO - BJOG : an international journal of obstetrics and gynaecology

JF - BJOG : an international journal of obstetrics and gynaecology

IS - 7

ER -

Assessing the usefulness of randomised trials in obstetrics and gynaecology

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this